Cargando…
Subcutaneous Immunotherapy (SCIT) with the New Polymerized Molecular Allergoid Alt a1: A Pilot Study in Children with Allergic Rhinitis Sensitized to Alternaria Alternata
Background: We followed the effects of a new SCIT with a chemically polymerized allergen Alt a1, evaluating the trend of clinical and functional parameters in an observational-prospective study. Methods: 42 children with AR and intermittent asthma sensitized to A.A.: 17 patients started SCIT (Modigo...
Autores principales: | Brindisi, Giulia, Gori, Alessandra, Anania, Caterina, Martinelli, Ivana, Capponi, Martina, De Castro, Giovanna, Zicari, Anna Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342936/ https://www.ncbi.nlm.nih.gov/pubmed/37445362 http://dx.doi.org/10.3390/jcm12134327 |
Ejemplares similares
-
Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany
por: Verheggen, Bram G, et al.
Publicado: (2015) -
(R)Evolution in Allergic Rhinitis Add-On Therapy: From Probiotics to Postbiotics and Parabiotics
por: Capponi, Martina, et al.
Publicado: (2022) -
Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis
por: Ren, Lei, et al.
Publicado: (2023) -
Purified Native and Recombinant Major Alternaria alternata Allergen (Alt a 1) Induces Allergic Asthma in the Murine Model
por: Vélez-del-Burgo, Ainara, et al.
Publicado: (2021) -
Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak
por: Brindisi, Giulia, et al.
Publicado: (2021)